Results 161 to 170 of about 4,849,377 (223)

Silver-<i>N</i>-Heterocyclic Complexes Against <i>Leishmania major</i>: In Vitro, In Vivo and In Silico Therapeutic Activities. [PDF]

open access: yesPharmaceuticals (Basel)
Şahin N   +6 more
europepmc   +1 more source

Leishmanicidal Action of the Peptides 19-4LF, 19-2.5 and 19-2.5LF Topically Administered on Cutaneous Lesions Caused by <i>Leishmania major</i>. [PDF]

open access: yesPharmaceutics
El-Dirany R   +6 more
europepmc   +1 more source

Molecular detection of Leishmania major human infections in the Zinder area, Niger. [PDF]

open access: yesBMC Infect Dis
Blaizot R   +7 more
europepmc   +1 more source

Persistent antigen is essential for sustaining <i>Leishmania major</i>-specific memory CD4<sup>+</sup> T cells and long-term immunity. [PDF]

open access: yesSci Adv
Mou Z   +12 more
europepmc   +1 more source

Nanofibrous patches for targeted therapy of cutaneous leishmaniasis caused by Leishmania major: a preclinical amphotericin B platform. [PDF]

open access: yesParasitol Res
Allahmoradi M   +8 more
europepmc   +1 more source

<i>In vitro</i> activity of gallium-protoporphyrin IX against <i>Leishmania major</i> and <i>Leishmania infantum</i>. [PDF]

open access: yesMicrobiol Spectr
Maestrini S   +5 more
europepmc   +1 more source

Genetic Diversity and Chromosomal Variations in the Iranian <i>Leishmania major</i> Strain: Insights into Pathogenicity and Drug Resistance. [PDF]

open access: yesAdv Biomed Res
Sharifian H   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy